27
Views
4
CrossRef citations to date
0
Altmetric
Original

Mitoxantrone and Paclitaxel Combination Chemotherapy in Metastatic Breast Cancer

, M.D., , Jr. M.D., , M.D., , M.D., , M.D., , M.D., , M.D., , Ph.D., , Ph.D. & , M.D. show all
Pages 225-233 | Published online: 31 Mar 2001

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Francesco Di Costanzo, Luigi Manzione, Silvia Gasperoni, Domenico Bilancia, Luigi Acito, Sabrina Angiona, Francesca Mazzoni & Lucio Giustini. (2004) Paclitaxel and Mitoxantrone in Metastatic Breast Cancer: A Phase II Trial of the Italian Oncology Group for Cancer Research. Cancer Investigation 22:3, pages 331-337.
Read now

Articles from other publishers (3)

Shiva Mehran, Afshin Taravati, Esfandiar Baljani, Yousef Rasmi & Zafar Gholinejad. (2021) Fever and breast cancer: A critical review of the literature and possible underlying mechanisms. Breast Disease 40:3, pages 117-131.
Crossref
Monika Lepiarczyk, Zbigniew Kałuża, Anna Bielawska, Robert Czarnomysy, Agnieszka Gornowicz & Krzysztof Bielawski. (2014) Cytotoxic activity of octahydropyrazin[2,1-a:5,4-a′]diisoquinoline derivatives in human breast cancer cells. Archives of Pharmacal Research 38:5, pages 628-641.
Crossref
Pennifer Erickson. 2009. Outcomes Assessment in Cancer. Outcomes Assessment in Cancer 31 68 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.